title: Comparison of clinical outcome with oral and inhaled bronchodilators in the management of wheezy children aged 1-59 months in the community: a randomised trial in Pakistan.
abstract: BACKGROUND
  Wheeze is a significant problem in children. There is a gradual trend of switching from oral to inhaled bronchodilator therapy. No randomised trials have been carried out in the community to compare the clinical outcome of two modes of therapy. If outcome with oral and inhaled bronchodilators is the same in young wheezers in developing countries, it will be easier to manage them.
  
  
  METHODS
  In a randomised multicentre trial, wheezy children aged 1-59 months with fast breathing and/or lower chest indrawing received oral or inhaled salbutamol at home after responding to up to three cycles of inhaled bronchodilators. They were re-assessed on days 3 and 5 for clinical outcome.
  
  
  RESULTS
  From May 2001 to August 2002, 780 children were enrolled; 390 each were randomised to oral and inhaled salbutamol. On day 5, 324 (83.1%) children in the oral and 328 (84.1%) in the inhaled group were completely well. There were no differences in clinical outcome of both modes of therapy.
  
  
  CONCLUSIONS
  The clinical outcome of children aged 1-59 months with wheeze is similar when treated with oral or inhaled salbutamol. Acute respiratory infection control programmes in developing countries should continue to use oral bronchodilators for the management of wheeze to save both time and money.
authors.affiliation: The Children's Hospital, Pakistan Institute of Medical Sciences, Islamabad, Pakistan. arichi99@hotmail.com
authors.forename: T
authors.initials: T
authors.lastname: Hazir
authors.forename: S
authors.initials: S
authors.lastname: Qazi
authors.forename: Y
authors.initials: Y
authors.lastname: Bin Nisar
authors.forename: S
authors.initials: S
authors.lastname: Ansari
authors.forename: S
authors.initials: S
authors.lastname: Maqbool
authors.forename: S
authors.initials: S
authors.lastname: Randhawa
authors.forename: Z
authors.initials: Z
authors.lastname: Kundi
authors.forename: R
authors.initials: R
authors.lastname: Asghar
authors.forename: S
authors.initials: S
authors.lastname: Aslam
mesh_terms: D000280:Administration, Inhalation; D000284:Administration, Oral; D000420:Albuterol / Q000008:administration & dosage*; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D010154:Pakistan; D012120:Respiration Disorders / Q000150:complications / Q000188:drug therapy*; D012135:Respiratory Sounds / Q000187:drug effects* / Q000209:etiology; D016896:Treatment Outcome
chemical_list: D001993:Bronchodilator Agents; D000420:Albuterol